Accoceberry I, Thellier M, Desportes-Livage I, Achbarou A, Biligui S, Danis M, Datry A
Unité INSERM 511, Laboratoire de Parasitologie-Mycologie, Centre Hospitalier-Universitaire de la Pitié-Salpêtrière, 75013 Paris, France.
J Clin Microbiol. 1999 Dec;37(12):4107-12. doi: 10.1128/JCM.37.12.4107-4112.1999.
Several hybridomas producing antibodies detected by indirect immunofluorescence antibody test (IFAT) were established by fusion of mouse myeloma SP2/O with spleen cells from BALB/c mice immunized against whole spores (protocol 1) or chitinase-treated spores (protocol 2) of Enterocytozoon bieneusi and were cloned twice by limiting dilutions. Two monoclonal antibodies (MAbs), 3B82H2 from protocol 1, isotyped as immunoglobulin M (IgM), and 6E52D9 from protocol 2, isotyped as IgG, were expanded in both ascites and culture. IFAT with the MAbs showed that both MAbs reacted exclusively with the walls of the spores of E. bieneusi, strongly staining the surface of mature spores, and produced titers of greater than 4,096. Immunogold electron microscopy confirmed the specific reactivities of both antibodies. No cross-reaction, either with the spores of the other intestinal microsporidium species Encephalitozoon intestinalis or with yeast cells, bacteria, or any other intestinal parasites, was observed. The MAbs were used to identify E. bieneusi spores in fecal specimens from patients suspected of having intestinal microsporidiosis. The IFAT was validated against standard staining methods (Chromotrope 2R and Uvitex 2B) and PCR. We report here the first description and characterization of two MAbs specific for the spore wall of E. bieneusi. These MAbs have great potential for the demonstration and species determination of E. bieneusi, and their application in immunofluorescence identification of E. bieneusi in stool samples could offer a new diagnostic tool for clinical laboratories.
通过将小鼠骨髓瘤SP2/O与用毕氏肠微孢子虫全孢子(方案1)或几丁质酶处理的孢子(方案2)免疫的BALB/c小鼠的脾细胞进行融合,建立了几种通过间接免疫荧光抗体试验(IFAT)检测到能产生抗体的杂交瘤,并通过有限稀释法进行了两次克隆。两种单克隆抗体(MAb),来自方案1的3B82H2,分型为免疫球蛋白M(IgM),以及来自方案2的6E52D9,分型为IgG,在腹水和培养物中均得到扩增。用这些单克隆抗体进行的IFAT表明,两种单克隆抗体均仅与毕氏肠微孢子虫的孢子壁发生反应,强烈染色成熟孢子的表面,并且产生的效价大于4096。免疫金电子显微镜证实了两种抗体的特异性反应性。未观察到与其他肠道微孢子虫物种肠道脑炎微孢子虫的孢子或酵母细胞、细菌或任何其他肠道寄生虫的交叉反应。这些单克隆抗体用于鉴定疑似患有肠道微孢子虫病患者粪便标本中的毕氏肠微孢子虫孢子。IFAT已针对标准染色方法(铬变素2R和乌洛托品2B)和PCR进行了验证。我们在此首次描述和表征了两种对毕氏肠微孢子虫孢子壁具有特异性的单克隆抗体。这些单克隆抗体在毕氏肠微孢子虫的展示和物种鉴定方面具有巨大潜力,并且它们在粪便样本中毕氏肠微孢子虫的免疫荧光鉴定中的应用可为临床实验室提供一种新的诊断工具。